D. Feig

发表

Pathogenesis of essential hypertension: historical paradigms and modern insights

T. Nakagawa, Richard J. Johnson, B. Rodriguez-Iturbe, 2008, Journal of hypertension.

Uric acid and cardiovascular risk.

Duk-Hee Kang, Richard J. Johnson, D. Kang, 2008, The New England journal of medicine.

A causal role for uric acid in fructose-induced metabolic syndrome.

Takahiko Nakagawa, Jaime Herrera-Acosta, Robert A Short, 2006, American journal of physiology. Renal physiology.

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

T. Nakagawa, Richard J. Johnson, B. Rodriguez-Iturbe, 2005, Hypertension.

A unifying pathway for essential hypertension.

Richard J. Johnson, B. Rodriguez-Iturbe, J. Herrera-Acosta, 2005, American journal of hypertension.

The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD

M. Lanaspa, Richard J. Johnson, L. Sánchez-Lozada, 2019, Nature Reviews Nephrology.

Serum Uric Acid and Risk of CKD in Type 2 Diabetes.

G. Russo, F. Viazzi, R. Pontremoli, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Uric acid and the origins of hypertension.

Richard J. Johnson, L. Sánchez-Lozada, D. Jalal, 2013, The Journal of pediatrics.

Uric Acid and Hypertension: Cause or Effect?

M. Kanbay, M. Segal, Richard J. Johnson, 2010, Current rheumatology reports.

Allopurinol and the Role of Uric Acid in Hypertension—Reply

Richard J. Johnson, D. Feig, 2009 .

Hormonal and cytokine effects of uric acid

T. Nakagawa, Richard J. Johnson, L. Sánchez-Lozada, 2006, Current opinion in nephrology and hypertension.

Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease.

T. Srinivas, T. Nakagawa, M. Segal, 2006, Kidney international.

A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid.

R. Frye, Richard J. Johnson, Y. Sautin, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Uric acid and hypertension

T. Nakagawa, Richard J. Johnson, D. Kang, 2006, Current hypertension reports.

Uric acid and Hypertension: An Update with Recommendations.

M. Lanaspa, T. Nakagawa, Richard J. Johnson, 2020, American journal of hypertension.

Prenatal programming: maybe not so hopeless after all?

D. Feig, 2009, American journal of hypertension.

Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.

T. Nakagawa, Richard J. Johnson, B. Rodriguez-Iturbe, 2006, Hypertension.

Serum uric acid and the risk of hypertension and chronic kidney disease

D. Feig, 2014, Current opinion in rheumatology.

The Role of Uric Acid in the Pathogenesis of Hypertension in the Young

D. Feig, 2012, Journal of clinical hypertension.

Chapter 5 – Renal Urate Metabolism inthe Fetus and Newborn

D. Feig, 2012 .

Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study

Craig S. Wong, V. D’Agati, C. Alpers, 2018, Kidney international reports.

Randomized Trial With Newly Diagnosed Essential Hypertension: A Effect of Allopurinol on Blood Pressure of Adolescents

Richard J. Johnson, D. Feig, Beth Soletsky, 2009 .

Persistent Disease Activity in Patients With Long-Standing Glomerular Disease

Craig S. Wong, B. Rovin, J. Klein, 2020, Kidney international reports.

Subclinical inflammation phenotypes and long‐term outcomes after pediatric kidney transplantation

R. Mannon, E. Mroczek-Musulman, D. Feig, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The role of uric acid in pediatric hypertension.

Richard J. Johnson, D. Feig, 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Mechanisms of mutation by oxidative DNA damage: reduced fidelity of mammalian DNA polymerase beta.

L. Loeb, D. Feig, 1993, Biochemistry.

Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia

G. Cutter, P. Muntner, J. Lebensburger, 2017, Pediatric Nephrology.

Severe anemia early in life as a risk factor for sickle-cell kidney disease.

I. Aban, J. Lebensburger, T. Howard, 2017, Blood.

Serum urate: a biomarker or treatment target in pediatric hypertension?

D. Feig, M. Yanik, 2013, Current opinion in cardiology.

Sour notes on sweet drinks.

D. Feig, 2009, The Journal of pediatrics.

Reactive Oxygen Species in Tumorigenesis 1

L. Loeb, D. Feig, T. Reid, 2006 .

Coincident Activation of Th2 T Cells with Onset of the Disease and Differential Expression of GRO-Gamma in Peripheral Blood Leukocytes in Minimal Change Disease

Cindy Zhou, Y. Lou, Richard J. Johnson, 2007, American Journal of Nephrology.

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

D. Feig, 2009, Current opinion in nephrology and hypertension.

Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children

A. Mott, D. Feig, B. Moffett, 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

The C proteins of heterogeneous nuclear ribonucleoprotein complexes interact with RNA sequences downstream of polyadenylation cleavage sites

T. Shenk, J. Wilusz, D. Feig, 1988, Molecular and cellular biology.

Calcium Oxalate Deposition in Renal Allografts: Morphologic Spectrum and Clinical Implications

L. Truong, W. Suki, J. Hicks, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy

I. Aban, J. Lebensburger, D. Askenazi, 2019, American journal of hematology.

Kidney implications of SARS-CoV2 infection in children

D. Feig, E. Bjornstad, M. Seifert, 2021, Pediatric Nephrology.

A Pilot Study Comparing Uric Acid and Biomarkers of Renal Injury and Inflammation in Pediatric Sickle Cell Disease at Vaso-Occlusive Crisis and Steady State

D. McClish, Wally R. Smith, D. Feig, 2019 .

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection

D. Gipson, G. Schwartz, H. Trachtman, 2015, Clinical pharmacology and therapeutics.

Uric acid, nephron number and the pathogenesis of essential hypertension

S. Karumanchi, T. Nakagawa, Richard J. Johnson, 2004 .

Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.

N. Brunetti‐Pierri, D. Harrison, N. Bryan, 2012, American journal of human genetics.

Hyperuricemia and abnormal nocturnal dipping impact glomerular filtration rate in patients with sickle cell anemia

I. Aban, J. Lebensburger, L. Hilliard, 2021, American journal of hematology.

Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial

S. Oparil, S. L. Bridges, P. Muntner, 2021, Arthritis & rheumatology.

Recent advances in the diagnosis and treatment of pheochromocytoma in children.

M. Hicks, D. Feig, D. Cass, 2007, American journal of surgery.

Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association

Rachel K. Johnson, N. Krebs, C. Anderson, 2017, Circulation.

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

K. Tuttle, Richard J. Johnson, B. Rodriguez-Iturbe, 2003, Hypertension.

Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA.

L. Loeb, D. Feig, L. Sowers, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Serum uric acid: a risk factor and a target for treatment?

T. Nakagawa, Richard J. Johnson, D. Kang, 2006, Journal of the American Society of Nephrology : JASN.

Oxygen radical induced mutagenesis is DNA polymerase specific.

L. Loeb, D. Feig, 1994, Journal of molecular biology.

Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome

I. Aban, J. Lebensburger, D. Askenazi, 2016, Pediatric Nephrology.

Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study

Craig S. Wong, V. D’Agati, M. Kretzler, 2020, Kidney international reports.

Reactive oxygen species in tumorigenesis.

L. Loeb, L A Loeb, D I Feig, 1994, Cancer research.

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.

S. Karumanchi, T. Nakagawa, Richard J. Johnson, 2004, Kidney international.

Cytomegalovirus and Epstein‐Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis

K. Fowler, D. Feig, G. Paulsen, 2019, Pediatric transplantation.

Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed

Richard J. Johnson, D. Feig, J. Kanellis, 2004, Nephrology.

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Richard J. Johnson, D. Feig, Beth Soletsky, 2008, JAMA.

Hyperuricemia and hypertension.

D. Feig, 2012, Advances in chronic kidney disease.

Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents

D. Feig, Beth Soletsky, 2012, Hypertension.

The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes.

Sara C. Fallon, D. Feig, M. Brandt, 2013, Journal of pediatric surgery.

Adverse childhood experiences are associated with vascular changes in adolescents that are risk factors for future cardiovascular disease

S. Mrug, D. Feig, M. Seifert, 2023, Pediatric Nephrology.

3-5 year longitudinal follow-up of pediatric patients after acute renal failure.

S. Goldstein, D. Askenazi, D. Feig, 2006, Kidney international.

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Takahiko Nakagawa, Steven Benner, Duk-Hee Kang, 2007, The American journal of clinical nutrition.

Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis.

S. Goldstein, E. Elenberg, D. Askenazi, 2004, Pediatrics.

Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature

R. Cron, M. Stoll, D. Feig, 2018, Pediatric Rheumatology.

Frequent hemodialysis with NxStage™ system in pediatric patients receiving maintenance hemodialysis

S. Goldstein, B. Warady, D. Feig, 2008, Pediatric Nephrology.

Smaller circuits for smaller patients: improving renal support therapy with Aquadex™

D. Askenazi, S. White, S. Borasino, 2016, Pediatric Nephrology.

Hyperuricemia in Childhood Primary Hypertension

Richard J. Johnson, D. Feig, 2003, Hypertension.

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome

K. Eldin, M. Hicks, S. Swartz, 2009, Pediatric nephrology (Berlin, West).

Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.

M. Kanbay, Richard J. Johnson, L. Sánchez-Lozada, 2011, Hypertension.

Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients

S. Goldstein, K. Upadhyay, D. Feig, 2011, Pediatric Nephrology.

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

T. Nakagawa, M. Segal, R. Glassock, 2009, Endocrine reviews.

Resurrection of uric acid as a causal risk factor in essential hypertension.

Richard J. Johnson, J. Herrera-Acosta, D. Kang, 2005, Hypertension.

Association between left ventricular mass index and cardiac function in pediatric dialysis patients

M. Taylor, T. Slesnick, E. Smith, 2012, Pediatric Nephrology.

CRP, Uric Acid, and Other Novel Factors in the Pathogenesis of Hypertension

D. Feig, 2011 .

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study

B. Hunt, L. Gunawardhana, A. Whelton, 2017, Journal of the American Heart Association.

Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.

K. Avis, D. Feig, D. Lozano, 2016, Journal of the American Society of Hypertension : JASH.

Uric acid and hypertension.

D. Feig, 2011, Seminars in nephrology.

Pediatrics: Uncontrolled hypertension in children on hemodialysis

M. Mitsnefes, D. Feig, 2010, Nature Reviews Nephrology.

Cost-Effectiveness of Ambulatory Blood Pressure Monitoring in the Initial Evaluation of Hypertension in Children

S. Swartz, P. Srivaths, D. Feig, 2008, Pediatrics.

Childhood hypertension is not a silent disease

D. Feig, Beth Croix, 2006, Pediatric Nephrology.

The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.

S. Oparil, P. Muntner, K. Saag, 2016, Contemporary clinical trials.

Sugar-sweetened beverages and hypertension.

D. Feig, 2010, Future cardiology.

Feig and Johnson Uric Acid in Childhood Hypertension

Richard J. Johnson, D. Feig, 2003 .

Uric acid and hypertension in adolescents.

D. Feig, 2005, Seminars in nephrology.

Drug contagion in Jerusalem: a pilot investigation of the Israeli drug use scene.

D. Feig, S. Einstein, 1979, The International journal of the addictions.

What are the key arguments against uric acid as a true risk factor for hypertension?

M. Kanbay, Richard J. Johnson, L. Sánchez-Lozada, 2013, HYPERTENSION.

Uric Acid in the Pathogenesis of Hypertension

D. Feig, 2013 .

Inaccuracy in Pediatric Outpatient Blood Pressure Measurement

D. Feig, Amber S. Podoll, M. Grenier, 2007, Pediatrics.

Trends in Blood Pressure and Hypertension Among US Children and Adolescents, 1999-2018

Byron C. Jaeger, E. Urbina, P. Muntner, 2021, JAMA network open.

Uric Acid Excretion Predicts Increased Blood Pressure Among American Adolescents of African Descent

M. Mrug, S. Mrug, D. Feig, 2017, The American journal of the medical sciences.

Mutagenesis by metal-induced oxygen radicals.

L. Loeb, D. Feig, T. Reid, 1994, Environmental health perspectives.

syndrome, diabetes, kidney disease, and cardiovascular disease Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic

A. Hofman, E. Block, A. Dehghan, 2008 .

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

V. Dharnidharka, R. Ettenger, B. Warshaw, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Diuretic-induced hyperuricemia does not decrease cardiovascular risk.

T. Srinivas, M. Segal, Richard J. Johnson, 2004, Journal of hypertension.

Sugar, salt, immunity and the cause of primary hypertension

M. Lanaspa, M. Kanbay, T. Nakagawa, 2023, Clinical kidney journal.

Reactive Oxygen Species in Tumorigenesis1

Thomas, D. Feig, M. Reid, 2006 .

Urate-Lowering Therapy and Chronic Kidney Disease Progression.

D. Feig, 2020, The New England journal of medicine.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Krzysztof Kiryluk, Matthias Kretzler, Brenda W Gillespie, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Uric acid and cardiovascular risk.

Richard J. Johnson, D. Kang, D. Feig, 2008, The New England journal of medicine.

Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients

Wally R. Smith, D. Feig, C. Kaspar, 2020, Pediatric Nephrology.

Pathogenesis of essential hypertension: historical paradigms and modern insights

T. Nakagawa, B. Rodriguez-Iturbe, L. Sánchez-Lozada, 2008, Journal of hypertension.

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

V. Dharnidharka, R. Ettenger, B. Warshaw, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.